uniQure
Develops one-time AAV gene therapies for serious diseases with unmet needs.
$49.46
After-hours close+0.76 (+1.55%)
At close$48.71(−1.73%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.82 | — | — |
| Jul 2026 | −$0.82 | −$1.22 | −48.4% |
| May 2026 | −$0.88 | −$0.85 | +3.4% |
| Mar 2026 | −$0.93 | −$0.56 | +39.8% |
| Nov 2025 | −$0.85 | −$1.38 | −62.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Apr 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Apr 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.82 | — | — | $6.2M | — | — |
| Jul 29, 2026 | −$0.82 | −$1.22 | −48.4% | $5.4M | $5.8M | +7.2% |
| May 5, 2026 | −$0.88 | −$0.85 | +3.4% | $5.2M | $3.6M | −31.6% |
| Mar 2, 2026 | −$0.93 | −$0.56 | +39.8% | $5.3M | $5.6M | +4.5% |
| Nov 10, 2025 | −$0.85 | −$1.38 | −62.4% | $4.8M | $3.7M | −23.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 29, 2025 | ||||||
| May 9, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 5, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 1, 2023 | ||||||
| May 9, 2023 | ||||||
| Feb 27, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 2, 2022 | ||||||
| Feb 25, 2022 | ||||||
| Oct 25, 2021 | ||||||
| Jul 26, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 1, 2021 | ||||||
| Oct 27, 2020 | ||||||
| Jul 30, 2020 | ||||||
| Apr 29, 2020 | ||||||
| Mar 2, 2020 | ||||||
| Oct 28, 2019 | ||||||
| Jul 29, 2019 | ||||||
| Apr 29, 2019 | ||||||
| Feb 28, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 8, 2018 | ||||||
| Apr 30, 2018 | ||||||
| Mar 14, 2018 | ||||||
| Nov 1, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 9, 2017 | ||||||
| Mar 15, 2017 | ||||||
| Nov 22, 2016 | ||||||
| Aug 25, 2016 | ||||||
| May 31, 2016 | ||||||
| Apr 4, 2016 | ||||||
| Nov 30, 2015 | ||||||
| Aug 27, 2015 | ||||||